Evaluation of D-dimer level as a biomarker of disease severity and mortality in patients with COVID-19

Kolotylo, Tetiana R.; Moskaliuk, Vasyl D.; Syrota, Borys V.; Balaniuk, Iryna V.; Melenko, Svitlana R.; Chernetska, Natalia V.; Boiko, Yuliia I.

dc.contributor.author	Kolotylo, Tetiana R.
dc.contributor.author	Moskaliuk, Vasyl D.
dc.contributor.author	Syrota, Borys V.
dc.contributor.author	Balaniuk, Iryna V.
dc.contributor.author	Melenko, Svitlana R.
dc.contributor.author	Chernetska, Natalia V.
dc.contributor.author	Boiko, Yuliia I.
dc.date.accessioned	2025-01-23T11:59:18Z
dc.date.available	2025-01-23T11:59:18Z
dc.date.issued	2023
dc.identifier.other	DOI: 10.36740/WLek202307118
dc.identifier.uri	http://dspace.bsmu.edu.ua:8080/xmlui/handle/123456789/26126
dc.description.abstract	The aim: To examine risk factors and evaluate the use of D-dimer as a biomarker of disease severity and mortality in patients with COVID-19. Conclusions: Thus, the level of D-dimer can be considered an important prognostic factor in COVID-19, as its level is elevated in the vast majority of patients with COVID-19 and correlates with a severe course and high mortality.	uk_UA
dc.language.iso	en	uk_UA
dc.publisher	Wiadomości Lekarskie / Medical Advances (часопис Польської медичної асоціації)	uk_UA
dc.subject	thrombosis	uk_UA
dc.subject	D-dimer	uk_UA
dc.subject	thromboembolism	uk_UA
dc.subject	coagulopathy	uk_UA
dc.subject	COVID-19	uk_UA
dc.title	Evaluation of D-dimer level as a biomarker of disease severity and mortality in patients with COVID-19	uk_UA
dc.type	Article	uk_UA